13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q3 2025 · Filed November 13, 2025 · Accession 0000904454-25-000587
Total Value
$503.7M
Positions
20
Other Managers
1
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $162.7M | 32.30% |
| 2 | Nanobiotix S.A. | NBTX | 5,623,816 | $106.2M | 21.09% |
| 3 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $54.7M | 10.85% |
| 4 | Rapport Therapeutics, Inc. | RAPP | 1,784,517 | $53.0M | 10.52% |
| 5 | CVRx, Inc. | CVRX | 4,103,430 | $33.1M | 6.57% |
| 6 | Legend Biotech Corporation | LEGN | 814,586 | $26.6M | 5.27% |
| 7 | Contineum Therapeutics Inc. | CTNM | 1,979,173 | $23.3M | 4.62% |
| 8 | Procept BioRobotics Corporation | PRCT | 357,939 | $12.8M | 2.54% |
| 9 | Xencor, Inc. | XNCR | 748,062 | $8.8M | 1.74% |
| 10 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $8.5M | 1.70% |
| 11 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $4.3M | 0.85% |
| 12 | Neumora Therapeutics, Inc. | NMRA | 1,849,445 | $3.4M | 0.67% |
| 13 | Vor Biopharma, Inc. | VOR | 53,732 | $2.6M | 0.52% |
| 14 | Rallybio Corporation | RLYB | 3,636,363 | $1.8M | 0.36% |
| 15 | Lyell Immunopharma Inc. | LYEL | 41,165 | $668,520 | 0.13% |
| 16 | Nano-X Imaging Ltd. | NNOX | 158,852 | $587,752 | 0.12% |
| 17 | Standard BioTools Inc | LAB | 311,967 | $405,557 | 0.08% |
| 18 | Adicet Bio, Inc. | ACET | 364,472 | $295,295 | 0.06% |
| 19 | BiomX Inc. | PHGE | 96,866 | $50,855 | 0.01% |
| 20 | Senseonics Holdings, Inc. | SENS | 54,621 | $23,804 | 0.00% |